Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neural diathesis-stress model of schizophrenia revisited: An update on recent findings considering illness stage and neurobiological and methodological complexities
Marita Pruessner, Alexis E. Cullen, Monica Aas, et al.
Neuroscience & Biobehavioral Reviews (2016) Vol. 73, pp. 191-218
Open Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation
Joanna Mikulska, Gabriela Juszczyk, Monika Gawrońska‐Grzywacz, et al.
Brain Sciences (2021) Vol. 11, Iss. 10, pp. 1298-1298
Open Access | Times Cited: 235
From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States
Deidre M. Anglin, Sabrina Ereshefsky, Mallory J. Klaunig, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 7, pp. 599-610
Open Access | Times Cited: 187
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 59
Unique Effects of Clozapine: A Pharmacological Perspective
Jibran Y. Khokhar, Angela M. Henricks, Emily D. K. Sullivan, et al.
Advances in pharmacology (2018), pp. 137-162
Open Access | Times Cited: 149
Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis
Alexis E. Cullen, Scarlett Holmes, Thomas A. Pollak, et al.
Biological Psychiatry (2018) Vol. 85, Iss. 1, pp. 35-48
Open Access | Times Cited: 129
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders
Shahram Bahrami, Nils Eiel Steen, Alexey Shadrin, et al.
JAMA Psychiatry (2020) Vol. 77, Iss. 5, pp. 503-503
Open Access | Times Cited: 111
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
Maria Jalbrzikowski, Rebecca A. Hayes, Stephen J. Wood, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 7, pp. 753-753
Open Access | Times Cited: 102
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 98
Stress during critical periods of development and risk for schizophrenia
Felipe V. Gomes, Xiyu Zhu, Anthony A. Grace
Schizophrenia Research (2019) Vol. 213, pp. 107-113
Open Access | Times Cited: 94
Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders
Monica Aas, Diego A. Pizzagalli, Jannicke Fjæra Laskemoen, et al.
Schizophrenia Research (2019) Vol. 213, pp. 65-71
Open Access | Times Cited: 84
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Elizabeth Appiah‐Kusi, Natalia Petros, Rebecca Wilson, et al.
Psychopharmacology (2020) Vol. 237, Iss. 4, pp. 1121-1130
Open Access | Times Cited: 75
Estrogens in schizophrenia: progress, current challenges and opportunities
Bodyl A. Brand, Janna N. de Boer, Iris E. Sommer
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 3, pp. 228-237
Open Access | Times Cited: 74
The role of norepinephrine in the pathophysiology of schizophrenia
Verónica Mäki-Marttunen, Ole A. Andreassen, Thomas Espeseth
Neuroscience & Biobehavioral Reviews (2020) Vol. 118, pp. 298-314
Open Access | Times Cited: 70
Toward recovery in schizophrenia: Current concepts, findings, and future research directions
Toshiaki Onitsuka, Yoji Hirano, Takanobu Nakazawa, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 76, Iss. 7, pp. 282-291
Closed Access | Times Cited: 45
Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis
Saahithh Redddi Patlola, Gary Donohoe, Declan P. McKernan
Journal of Psychiatric Research (2023) Vol. 160, pp. 126-136
Closed Access | Times Cited: 40
Psychosocial stress, interpersonal sensitivity, and social withdrawal in clinical high risk for psychosis: a systematic review
Anna Georgiades, Aljawharah Almuqrin, P. Rubinic, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 8
Salivary cortisol measures across the clinical stages of psychosis: An individual participant data (IPD) meta-analysis
Susanne Häußler, Uzma Zahid, Fern Day, et al.
Psychoneuroendocrinology (2025), pp. 107283-107283
Closed Access | Times Cited: 1
Case Report: Recurrent psychotic episodes in the setting of non-COVID-19 upper respiratory viral infection
Zahraa Atoui, Yi Ting Liu, Andrew Lee, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access | Times Cited: 1
Environmental adversities and psychotic symptoms: The impact of timing of trauma, abuse, and neglect
Inga Schalinski, Susanne Breinlinger, Vanessa Hirt, et al.
Schizophrenia Research (2017) Vol. 205, pp. 4-9
Closed Access | Times Cited: 83
The role of childhood trauma in cognitive performance in schizophrenia and bipolar disorder – A systematic review
Maria R. Dauvermann, Gary Donohoe
Schizophrenia Research Cognition (2018) Vol. 16, pp. 1-11
Open Access | Times Cited: 74
Gender differences in childhood trauma in first episode psychosis: Association with symptom severity over two years
Marita Pruessner, Suzanne King, Nadia Vracotas, et al.
Schizophrenia Research (2018) Vol. 205, pp. 30-37
Closed Access | Times Cited: 62
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia
Lotta-Katrin Pries, Jim van Os, Margreet ten Have, et al.
JAMA Psychiatry (2020) Vol. 77, Iss. 12, pp. 1296-1296
Open Access | Times Cited: 61
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
Rita Khoury, Henry A. Nasrallah
Schizophrenia Research (2018) Vol. 199, pp. 31-38
Closed Access | Times Cited: 60
The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
Stephan F. Taylor, Tyler Grove, Vicki L. Ellingrod, et al.
Schizophrenia Bulletin (2019) Vol. 45, Iss. 6, pp. 1170-1183
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top